BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 26879873)

  • 1. Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States.
    Patil S; Willett O; Thompkins T; Hermann R; Ramanathan S; Cornett EM; Fox CJ; Kaye AD
    Curr Pain Headache Rep; 2016 Mar; 20(3):15. PubMed ID: 26879873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin in pain treatment.
    Colhado OC; Boeing M; Ortega LB
    Rev Bras Anestesiol; 2009; 59(3):366-81. PubMed ID: 19488551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Göbel H; Heinze A; Heinze-Kuhn K; Austermann K
    Nervenarzt; 2001 Apr; 72(4):261-74. PubMed ID: 11320861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence based medicine on the use of botulinum toxin for headache disorders.
    Schulte-Mattler WJ; Leinisch E
    J Neural Transm (Vienna); 2008; 115(4):647-51. PubMed ID: 17994180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA; Buwalda J
    J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA for the treatment of headache: an updated review.
    Talbet JH; Elnahry AG
    J Integr Neurosci; 2022 Jan; 21(1):37. PubMed ID: 35164473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlabeled uses of botulinum toxins: a review, part 2.
    Cheng CM; Chen JS; Patel RP
    Am J Health Syst Pharm; 2006 Feb; 63(3):225-32. PubMed ID: 16434781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW
    Headache; 2003; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BOTOX: a review.
    Mendez-Eastman SK
    Plast Surg Nurs; 2003; 23(2):64-9. PubMed ID: 14533572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
    Ahmed K; Oas KH; Mack KJ; Garza I
    Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
    von Lindern JJ; Niederhagen B; Bergé S; Appel T
    J Oral Maxillofac Surg; 2003 Jul; 61(7):774-8. PubMed ID: 12856249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for antinociceptive activity of botulinum toxin type A in pain management.
    Aoki KR
    Headache; 2003; 43 Suppl 1():S9-15. PubMed ID: 12887389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study.
    Freund BJ; Schwartz M
    Headache; 2000 Mar; 40(3):231-6. PubMed ID: 10759926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on the antinociceptive mechanism hypothesis of botulinum toxin A.
    Aoki KR; Francis J
    Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S28-33. PubMed ID: 21999893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A use in piriformis muscle syndrome: a pilot study.
    Childers MK; Wilson DJ; Gnatz SM; Conway RR; Sherman AK
    Am J Phys Med Rehabil; 2002 Oct; 81(10):751-9. PubMed ID: 12362115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
    Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.